Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc. 10-K Item 1C cybersecurity disclosure describing its NIST-based cybersecurity risk management program, third-party vendor risk assessments, and governance by the Finance organization with Audit Committee oversight. As of the date of the report, the Company states it has not identified any cybersecurity threat or incident reasonably likely to have a material effect on its business, operations, or financial condition. No specific breach incident is disclosed.